Literature DB >> 8319923

Ischemia/reperfusion impairs mitochondrial energy conservation and triggers O2.- release as a byproduct of respiration.

H Nohl1, V Koltover, K Stolze.   

Abstract

The aim of the present study was to elucidate the role of mitochondria in the development of heart failure following ischemia/reperfusion. Although mitochondria were increasingly assumed to be responsible for the establishment of an oxidative stress situation the lack of suitable methods to prove it required new concepts for an evaluation of the validity of this hypothesis. The principal idea was to expose isolated mitochondria to metabolic conditions which are developed during ischemia/reperfusion in the cell (anoxia, lactogenesis) and study how they respond. Heart mitochondria treated in that way responded with an incomplete collapse of the transmembraneous proton gradient, thereby impairing respiration-linked ATP generation. The membrane effect affected also the proper control of e- transfer through redox-cycling ubisemiquinone. Electrons were found to leak at this site from its normal pathway to O2 suggesting that ubisemiquinone becomes an active O2.- generator. It was concluded from these observations that mitochondria are likely to play a pathogenetic role in the reperfusion injury of the heart both, by an impairment of energy conservation and their transition to a potent O2.(-)-radical generator. Furthermore, there is considerable evidence that the exogenous NADH-dehydrogenase of heart mitochondria is mainly responsible for functional changes of these organelles during ischemia/reperfusion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8319923     DOI: 10.3109/10715769309147486

Source DB:  PubMed          Journal:  Free Radic Res Commun        ISSN: 8755-0199


  6 in total

1.  Effect of venotropic drugs on the respiratory activity of isolated mitochondria and in endothelial cells.

Authors:  D Janssens; E Delaive; A Houbion; F Eliaers; J Remacle; C Michiels
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

2.  Short-term impairment of energy production in isolated rat liver mitochondria by hypoxia/reoxygenation: involvement of oxidative protein modification.

Authors:  L Schild; T Reinheckel; I Wiswedel; W Augustin
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

3.  The antihypertensive drug carvedilol inhibits the activity of mitochondrial NADH-ubiquinone oxidoreductase.

Authors:  Tiziana Cocco; Giuseppe Cutecchia; Grazia Montedoro; Michele Lorusso
Journal:  J Bioenerg Biomembr       Date:  2002-08       Impact factor: 2.945

4.  Estrogen, mitochondria, and growth of cancer and non-cancer cells.

Authors:  Quentin Felty; Deodutta Roy
Journal:  J Carcinog       Date:  2005-01-15

5.  Carvedilol enhances the antioxidant effect of vitamins E and C in chronic Chagas heart disease.

Authors:  Patrícia Budni; Roberto Coury Pedrosa; Eduardo Monguilhott Dalmarco; Juliana Bastos Dalmarco; Tânia Sílvia Frode; Danilo Wilhelm Filho
Journal:  Arq Bras Cardiol       Date:  2013-09-06       Impact factor: 2.000

6.  Effects of leucine-enkephalin on catalase activity and hydrogen peroxide levels in the haemolymph of the Pacific Oyster (Crassostrea gigas).

Authors:  Dong-wu Liu; Zhi-wei Chen; Hong-zhi Xu
Journal:  Molecules       Date:  2008-04-15       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.